These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 328355

  • 1. [Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic blocking agent. (6) Pharmacokinetics of carteolol in the rat, dog, rabbit and man].
    Morita S, Irie Y, Sakuragi S, Kori H.
    Nihon Yakurigaku Zasshi; 1977 Mar; 73(2):229-35. PubMed ID: 328355
    [Abstract] [Full Text] [Related]

  • 2. [Metabolic fate of carteolol hydrochloride (OPC-1085), a new beta-adrenergic agent. (3) Autoradiographic total body distribution studies in mice].
    Kohri H, Morita S, Nakagawa K, Nishino H.
    Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):341-50. PubMed ID: 9341
    [Abstract] [Full Text] [Related]

  • 3. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
    Morita S, Iinuma M, Kido M, Sakuragi S, Kohri H, Nishino H.
    Arzneimittelforschung; 1977 Apr; 27(12):2380-3. PubMed ID: 23800
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
    Ishizaki T, Ohnishi A, Sasaki T, Kushida K, Horai Y, Chiba K, Suganuma T.
    Eur J Clin Pharmacol; 1983 Apr; 25(1):95-101. PubMed ID: 6137389
    [Abstract] [Full Text] [Related]

  • 5. [Metabolic fate of carteolol hydrochloride [5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride, OPC-1085], a new beta-blocker. V. Identification of metabolites in rat, dog and human (author's transl)].
    Mori H, Kido M, Murakami N, Morita S, Kohri H.
    Yakugaku Zasshi; 1977 Apr; 97(4):305-8. PubMed ID: 327055
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J, Verhaeghe T, Willems B, Bode W, Lavrijsen K, Meuldermans W.
    Arzneimittelforschung; 2003 Apr; 53(7):486-95. PubMed ID: 12918214
    [Abstract] [Full Text] [Related]

  • 7. [Studies on pharmacokinetics and biotransformation of reproterol in animal and man (author's transl)].
    Niebch G, Obermeier K, Vergin H, Thiemer K.
    Arzneimittelforschung; 1977 Apr; 27(12):37-45. PubMed ID: 576829
    [Abstract] [Full Text] [Related]

  • 8. [Animal experimental studies on the pharmacokinetics of carteolol].
    Lang W.
    Arzneimittelforschung; 1983 Apr; 33(2a):286-9. PubMed ID: 6682319
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H, Takagi K, Hasegawa T, Ogura Y, Mizukami Y, Satake T.
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [Abstract] [Full Text] [Related]

  • 10. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK, Lee SJ, Kim YG, Kim SH, Kim JW, Kim T, Lee MG.
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [Abstract] [Full Text] [Related]

  • 11. l-Bunolol and propranolol: oral and intravenous beta-adrenoceptor blocking activity in rats compared to dogs and humans.
    Kaplan HR, Commarato MA, Lattime EC.
    J Pharm Sci; 1978 Jan; 67(1):132-3. PubMed ID: 22739
    [Abstract] [Full Text] [Related]

  • 12. Cardiac electrophysiologic action of carteolol hydrochloride (OPC-1085), a new beta-adrenergic blocking agent.
    Watanabe Y, Toda H, Ozawa M.
    Pacing Clin Electrophysiol; 1978 Jul; 1(3):292-305. PubMed ID: 82947
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.
    Mukai H, Watanabe S, Morino A.
    Arzneimittelforschung; 1999 Jun; 49(6):527-32. PubMed ID: 10417870
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of sulpiride after oral and intravenous administration in the rat and the dog.
    Segura J, Borja L, Bakke OM.
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):88-95. PubMed ID: 999405
    [Abstract] [Full Text] [Related]

  • 15. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 16. [Ambroxol, comparative studies of pharmacokinetics and biotransformation in rat, rabbit, dog and man (author's transl)].
    Hammer R, Bozler G, Jauch R, Koss FW, Hadamovsky H.
    Arzneimittelforschung; 1978 Oct; 28(5a):899-903. PubMed ID: 581988
    [Abstract] [Full Text] [Related]

  • 17. Felbamate pharmacokinetics in the rat, rabbit, and dog.
    Adusumalli VE, Yang JT, Wong KK, Kucharczyk N, Sofia RD.
    Drug Metab Dispos; 1991 Oct; 19(6):1116-25. PubMed ID: 1687019
    [Abstract] [Full Text] [Related]

  • 18. Intracerebral penetration of carteolol hydrochloride in rats.
    Kudo S, Umehara K, Abe Y, Furukawa M, Odomi M.
    Psychopharmacology (Berl); 1997 Jun; 131(4):388-93. PubMed ID: 9226741
    [Abstract] [Full Text] [Related]

  • 19. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL, Türck D, von Hodenberg A, Vollmer KO, McNally WP, DeHart PD, Hanson BJ, Bockbrader HN, Chang T.
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [Abstract] [Full Text] [Related]

  • 20. The absorption and elimination of metoclopramide in three animal species.
    Bakke OM, Segura J.
    J Pharm Pharmacol; 1976 Jan; 28(1):32-9. PubMed ID: 6647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.